Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis
2011
The Role of SHP-2 in Blood Cell Development and Cancer
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Liu Xia, Qu Cheng-Kui
Primary Institution: Case Western Reserve University
Hypothesis
How do mutations in the SHP-2 protein affect blood cell development and contribute to leukemia?
Conclusion
Mutations in the SHP-2 protein are linked to various blood disorders, including leukemia, by disrupting normal signaling pathways.
Supporting Evidence
- SHP-2 is critical for hematopoietic cell development and function.
- Mutations in SHP-2 are associated with Noonan syndrome and leukemia.
- SHP-2 plays a positive role in hematopoiesis and immune responses.
- Different mutations in SHP-2 can lead to either activation or inactivation of its function.
Takeaway
SHP-2 is a protein that helps blood cells grow and function, and when it has mutations, it can lead to blood cancers.
Methodology
The study reviews existing literature on SHP-2's role in hematopoiesis and leukemogenesis, focusing on its signaling pathways and mutations.
Limitations
The mechanisms by which SHP-2 mutations lead to disease are not fully understood.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website